Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

Disorders of Hemostasis

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

Humoral Immune Responses

Humoral Immune Responses

Venous Thrombosis I: Introduction

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...

Venous Thrombosis III: Interprofessional Care

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...

Phosphoinositides and PIPs

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Portable Home-Use Triglyceride Meter Demonstrates Good Agreement With Plasma Laboratory Measures During Pregnancies Complicated by Metabolic Disease.

Endocrinology, diabetes & metabolism·2026

Same author

Influence of secretome from porcine cardiosphere-derived cells on porcine macrophage polarization and their possible implications for cardiac remodeling post-myocardial infarction <i>in vitro</i>.

Frontiers in cell and developmental biology·2025

Same author

Diffuse alveolar hemorrhage as a clinical manifestation of cardiac angiosarcoma in a pregnant woman with antiphospholipid syndrome: case report and review of the literature.

Ecancermedicalscience·2025

Same author

Treatment outcomes in sinonasal aspergillosis in dogs in the United Kingdom: 436 cases (2011-2021).

The Journal of small animal practice·2025

Same author

Impact of heteroresistance on treatment outcomes of people with drug-resistant TB.

IJTLD open·2024

Same author

Diagnostic findings in sinonasal aspergillosis in dogs in the United Kingdom: 475 cases (2011-2021).

The Journal of small animal practice·2024

Search research articles

Related Experiment Video

Updated: May 27, 2026

Ferric Chloride-induced Murine Thrombosis Models

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

Immunophilins and thrombotic disorders.

E Lopez¹, J A Rosado, P C Redondo

¹Department of Physiology, University of Extremadura, 10003 Cáceres, Spain.

Current Medicinal Chemistry

|November 18, 2011

Summary

Immunophilins are proteins vital for cell function, particularly in immune responses. This review explores their less-understood role in human platelets and potential links to drug side effects.

Area of Science:

Biochemistry
Immunology
Cell Biology

Background:

Immunophilins are proteins with peptidyl prolyl-isomerase (PPI-ase) activity, essential for protein folding and cellular functions.
Their role in leukocytes is well-studied, particularly in T cell activation and immune responses, leading to successful immunosuppressive drugs like cyclosporine A.
However, their function in other cell types, like platelets, remains largely unexplored.

Purpose of the Study:

To review the current understanding of immunophilin expression and physiological function in human platelets.
To highlight the potential regulatory role of immunophilins in platelet function.
To connect observed clinical side effects of immunophilin-binding drugs with platelet function.

Main Methods:

Literature review of existing studies on immunophilins in various cell types.

More Related Videos

Electrolytic Inferior Vena Cava Model (EIM) of Venous Thrombosis

Electrolytic Inferior Vena Cava Model (EIM) of Venous Thrombosis

Published on: July 12, 2011

Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice

Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice

Published on: April 2, 2013

Related Experiment Videos

Last Updated: May 27, 2026

Ferric Chloride-induced Murine Thrombosis Models

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

Electrolytic Inferior Vena Cava Model (EIM) of Venous Thrombosis

Electrolytic Inferior Vena Cava Model (EIM) of Venous Thrombosis

Published on: July 12, 2011

Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice

Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice

Published on: April 2, 2013

Analysis of clinical trial data reporting side effects related to thrombosis and platelet count.

Synthesis of evidence suggesting immunophilin involvement in platelet physiology.

Main Results:

Immunophilins are expressed in human platelets, though their specific functions are not fully elucidated.
Clinical observations suggest a link between immunophilin-binding drugs and adverse effects on platelet count and thrombosis.
This implies a potential regulatory role for immunophilins in platelet activation and hemostasis.

Conclusions:

Further research is needed to fully understand the physiological roles of immunophilins in human platelets.
Investigating immunophilins in platelets may reveal new therapeutic targets for managing thrombosis and improving drug safety.
This review underscores the importance of exploring immunophilin functions beyond leukocytes.